These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 61488)

  • 1. Intravenous prostaglandin E1 in severe peripheral vascular disease.
    Carlson LA; Olsson AG
    Lancet; 1976 Oct; 2(7989):810. PubMed ID: 61488
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical experiences with prostaglandin E1 in severe peripheral artery disease].
    Carlson LA; Jogestrand T; Kaijser L; Olsson AG
    Lakartidningen; 1977 Aug; 74(31):2629-33. PubMed ID: 895269
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical observations with intravenous prostaglandin E1 in peripheral vascular disease.
    Feldman SM; Alpert J; Dick LS; Brief DK; Goldenkranz R; Brener BJ; Parsonnet V
    J Med Soc N J; 1982 Dec; 79(13):985-7. PubMed ID: 6961223
    [No Abstract]   [Full Text] [Related]  

  • 4. Intravenous infusion of prostaglandin E1 (PGE1) in management of limb ischemia.
    Sethi GK; Bridgman AH; King L; Scott SM
    Am Surg; 1986 Sep; 52(9):474-8. PubMed ID: 3752724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healing of ischaemic ulcers by intravenous prostaglandin E1 in a woman with thrombangitis obliterans.
    Olsson AG; Thyresson N
    Acta Derm Venereol; 1978; 58(5):467-72. PubMed ID: 82360
    [No Abstract]   [Full Text] [Related]  

  • 6. Prostaglandin E1 in severe lower limb ischaemia: a double-blind controlled trial.
    Telles GS; Campbell WB; Wood RF; Collin J; Baird RN; Morris PJ
    Br J Surg; 1984 Jul; 71(7):506-8. PubMed ID: 6375799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preliminary results of prostaglandin E1 therapy in peripheral obliterating arteriopathy].
    Pilger E; Juan H
    Wien Klin Wochenschr; 1983 Apr; 95(8):263-6. PubMed ID: 6683910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary experience with prostaglandins E1 and I2 in peripheral vascular disease.
    Pardy BJ; Lewis JD; Eastcott HH
    Surgery; 1980 Dec; 88(6):826-32. PubMed ID: 7003784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [1st experiences with prostaglandin E1 long-term intra-arterial perfusion in advanced arterial occlusive disease of the lower extremities stage IV].
    Gruss JD; Kawai S; Karadedos C; Bartels D
    Dtsch Med Wochenschr; 1978 Oct; 103(41):1624-5. PubMed ID: 699778
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of intra-arterial infusion of PGE1 in patients with severe ischemia of lower extremity.
    Sethi GK; Scott SM; Takaro T
    J Cardiovasc Surg (Torino); 1980; 21(2):185-92. PubMed ID: 7364862
    [No Abstract]   [Full Text] [Related]  

  • 11. Prostaglandin E1 in obstructive peripheral vascular disease.
    Fernandez NA; Rosenberg V; Lee M; Singer A
    Mt Sinai J Med; 1983; 50(3):213-7. PubMed ID: 6604865
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical experience with prostaglandin E1 in the treatment of arteriosclerosis obliterans. A preliminary report.
    Ambrus JL; Taheri P; Killion D; Donaldson G
    J Med; 1983; 14(1):1-15. PubMed ID: 6577118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin therapy in severe limb ischemia.
    Pardy BJ; Eastcott HH
    World J Surg; 1983 May; 7(3):353-62. PubMed ID: 6349140
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of cardiovascular disease with prostaglandins.
    Szczeklik A
    Vasa; 1984; 13(4):360-4. PubMed ID: 6393628
    [No Abstract]   [Full Text] [Related]  

  • 15. Prostanoids for chronic critical leg ischemia. A randomized, controlled, open-label trial with prostaglandin E1. The ICAI Study Group. Ischemia Cronica degli Arti Inferiori.
    Ann Intern Med; 1999 Mar; 130(5):412-21. PubMed ID: 10068415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of intravenous administration of prostaglandin E1 on cerebral circulation in patients with cerebrovascular disease.
    Kuriyama Y; Nukada T; Aoyama T; Abe H
    Med J Osaka Univ; 1976 Mar; 26(3-4):111-6. PubMed ID: 979857
    [No Abstract]   [Full Text] [Related]  

  • 17. Hemodynamic changes during intraarterial administration of prostaglandin E1 in healthy subjects.
    Brecht T; Eryilmaz-Ayaz M
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():355-7. PubMed ID: 3159223
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical effects of intravenously administered prostaglandin E1 in patients with rest pain due to peripheral obliterative arterial disease (POAD)--a preliminary report on a placebo-controlled double-blind study.
    Diehm C; Stammler F; Hübsch-Müller C; Eckstein HH; Simini B
    Vasa Suppl; 1987; 17():52-6. PubMed ID: 3551154
    [No Abstract]   [Full Text] [Related]  

  • 19. Surgical re-establishment of the arterial circulation in the leg in Buerger's disease--with special reference to the efficacy of prostaglandin E1 used concomitantly.
    Okamoto Y; Nakayama K; Watanabe H; Osaragi M
    Nihon Geka Hokan; 1981 May; 50(3):501-8. PubMed ID: 7197904
    [No Abstract]   [Full Text] [Related]  

  • 20. Prostaglandin E1 as an adjuvant therapy in the event of femoropopliteal and crural great saphenous vein in situ bypass surgery.
    Fietze-Fischer B; Gruss JD; Bartels D; Vargas-Montano H; Stritter W
    Vasa Suppl; 1987; 17():23-5. PubMed ID: 3470961
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.